- Home
- JANX vs ZD Comparison
JANX vs ZD Comparison
Compare JANX & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- ZD
- Stock Information
- Founded
- JANX 2017
- ZD 1995
- Country
- JANX United States
- ZD United States
- Employees
- JANX N/A
- ZD N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- ZD Advertising
- Sector
- JANX Health Care
- ZD Consumer Discretionary
- Exchange
- JANX Nasdaq
- ZD Nasdaq
- Market Cap
- JANX 1.4B
- ZD 1.6B
- IPO Year
- JANX 2021
- ZD 1999
- Fundamental
- Price
- JANX $27.01
- ZD $38.05
- Analyst Decision
- JANX Strong Buy
- ZD Hold
- Analyst Count
- JANX 11
- ZD 5
- Target Price
- JANX $76.55
- ZD $41.80
- AVG Volume (30 Days)
- JANX 927.5K
- ZD 490.3K
- Earning Date
- JANX 11-05-2025
- ZD 11-06-2025
- Dividend Yield
- JANX N/A
- ZD N/A
- EPS Growth
- JANX N/A
- ZD N/A
- EPS
- JANX N/A
- ZD 1.48
- Revenue
- JANX $439,000.00
- ZD $1,447,248,000.00
- Revenue This Year
- JANX N/A
- ZD $8.37
- Revenue Next Year
- JANX $91.66
- ZD $3.95
- P/E Ratio
- JANX N/A
- ZD $25.77
- Revenue Growth
- JANX N/A
- ZD 5.94
- 52 Week Low
- JANX $21.73
- ZD $28.55
- 52 Week High
- JANX $71.71
- ZD $60.62
- Technical
- Relative Strength Index (RSI)
- JANX 59.54
- ZD 53.76
- Support Level
- JANX $25.62
- ZD $35.64
- Resistance Level
- JANX $27.70
- ZD $38.12
- Average True Range (ATR)
- JANX 1.56
- ZD 1.52
- MACD
- JANX 0.30
- ZD -0.12
- Stochastic Oscillator
- JANX 69.68
- ZD 65.37
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About ZD Ziff Davis Inc.
Ziff Davis Inc is a focused digital media and internet company whose portfolio includes brands in technology, entertainment, shopping, health, cybersecurity, and martech. It has two reportable segments: Digital Media and Cybersecurity and Martech. The company's brands include Mashable, Ookla, Offers.com, IGN, and VPN among others. The majority of revenue is generated from Digital Media.